Final Rule requires CMOs, GPOs to report annual payments to doctors

A final rule published by the Centers for Medicare and Medicaid Services (CMS) requires drug manufactures, including contract manufacturing organizations (CMOs) and group purchasing organizations (GPOs) to report annual payments to physicians or investment interests...

Mega-Trials: the new norm?

Numerous pharmaceuticals are approved and marketed based on the premise that they favorably change disease state-biomarkers. However, recent data has shown that altering the biomarkers indicative of disease does not necessarily translate to ameliorated health.  In an...